» Articles » PMID: 38693818

The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer

Overview
Specialty Endocrinology
Date 2024 May 2
PMID 38693818
Authors
Affiliations
Soon will be listed here.
References
1.
Kim M, Lee J, Hyun M, Song Y . Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study. Endocrinol Metab (Seoul). 2024; 39(2):288-299. PMC: 11066454. DOI: 10.3803/EnM.2023.1815. View

2.
Zhang H, Yang Y, Gao C, Tian L . Effect of Thyroid-Stimulating Hormone Suppression Therapy on Cardiac Structure and Function in Patients With Differentiated Thyroid Cancer After Thyroidectomy: A Systematic Review and Meta-Analysis. Endocr Pract. 2023; 30(2):177-186. DOI: 10.1016/j.eprac.2023.11.006. View

3.
Goldfarb M, Franco A . Survivorship, Quality of Life, and Transition to Adult Care for Pediatric and Adolescent Thyroid Cancer Survivors. Thyroid. 2022; 32(12):1471-1476. DOI: 10.1089/thy.2022.0407. View

4.
Kress E, Samarut J, Plateroti M . Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality?. Mol Cell Endocrinol. 2009; 313(1-2):36-49. DOI: 10.1016/j.mce.2009.08.028. View

5.
Obeid L, Dhillon H, Tan S, Vardy J . Is there a need for change in cancer survivorship care? A qualitative exploration of survivor experiences and needs at the Sydney Cancer Survivorship Centre Clinic. Support Care Cancer. 2023; 31(12):642. PMC: 10584705. DOI: 10.1007/s00520-023-08102-w. View